secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOGEN INC. (BIIB)
CIK:        0000875045
Form:       8-K
Filed at:   2023-11-08T23:59:59+00:00
Accession:  0001193125-23-273579
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Biogen elects Monish Patolawala to board effective Jan 1, 2024
--------------------------------------------------------------

- Monish Patolawala elected as director to fill a vacancy; term expires at 2024 Annual Meeting.
- Patolawala qualifies as an audit committee financial expert; expected to join Audit Committee.
- He will enter into standard indemnification agreement with Biogen.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/875045/000119312523273579/0001193125-23-273579-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/875045/000119312523273579/d454419d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-273579

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer